St John's Wort in a Memory Supplement
The short version
St John's wort (Hypericum perforatum) is a genuinely effective herbal antidepressant for mild to moderate depression. It is also one of the most clinically significant herb–drug interactions in the pharmacopoeia. It induces the CYP3A4 enzyme and the P-glycoprotein transporter, which lowers the blood level of a very large number of medicines and can make them stop working.
- Documented failures include oral contraceptives, ciclosporin in transplant patients and HIV antiretrovirals.
- With SSRIs, SNRIs, triptans or tramadol it can cause serotonin syndrome.
- Its presence in a memory formula is the concern, because that market skews older — and therefore more medicated.
Why this interaction is different from most
Most herb–drug interaction warnings are precautionary: theoretically plausible, rarely demonstrated. St John's wort is the opposite. Its interactions are documented in controlled pharmacokinetic studies and in clinical case reports with real consequences, and they are severe enough that regulators in several countries have issued formal warnings to prescribers.
The mechanism is induction rather than inhibition, which is why it is so wide-ranging. St John's wort activates the pregnane X receptor, which upregulates production of CYP3A4 — an enzyme involved in metabolising something on the order of half of all prescription drugs — and of P-glycoprotein, a transporter that pumps drugs back out of cells and out of the gut. More enzyme and more transporter means the drug is cleared faster and less of it reaches the target.
Inhibition makes a drug too strong. Induction makes it disappear. The second is harder to notice, because nothing happens — including the thing the drug was supposed to do.
The interactions that matter most
- Oral contraceptives. Reduced hormone levels, with breakthrough bleeding and unintended pregnancies reported. Anyone relying on the pill needs to know this before taking anything containing St John's wort.
- Ciclosporin and tacrolimus. Transplant rejection has been reported after patients started St John's wort. This is the case series that made the interaction famous among clinicians.
- HIV antiretrovirals. Reduced levels of protease inhibitors and NNRTIs, risking loss of viral suppression and resistance.
- Warfarin. Reduced anticoagulant effect and a lower INR, meaning less protection against clots.
- Digoxin. Reduced levels, in a drug with a narrow therapeutic window.
- Some anticancer drugs, including irinotecan and imatinib — reduced exposure to a treatment where that matters enormously.
- Serotonergic drugs. SSRIs, SNRIs, triptans, tramadol. Here the risk runs the other way: additive serotonergic activity, potentially causing serotonin syndrome, which is a medical emergency.
Does a smaller dose make it safe?
Less risky, probably. Safe, not reliably — and the label usually cannot tell you which.
Enzyme induction by St John's wort is driven largely by hyperforin, one of its constituents. Extracts standardised to low hyperforin content produce substantially less induction, which is why some European products are formulated that way deliberately. Induction is also dose-related, so a smaller amount generally means less effect.
The catch is what gets printed. Labels in this category typically state standardisation to hypericin — the "0.3% extract" figure you see — because that is the traditional marker. Hypericin is not the compound driving the induction. So a label can tell you the hypericin standardisation and tell you nothing at all about the hyperforin content that actually determines the interaction risk.
The practical consequence: you cannot rule out the interaction from the label. That is why the advice is to ask a pharmacist rather than to do arithmetic.
Why a memory supplement is the wrong place for it
There is a defensible design argument for including it. Low mood genuinely impairs concentration, working memory and recall, and treating the mood can improve the cognition. As a formulation idea it is not silly.
The problem is who buys memory supplements. That market skews substantially older, and older adults take more prescription medicines — polypharmacy is the norm past 65, not the exception. So an ingredient whose defining property is interfering with other medicines is being placed in the product most likely to be taken by people on several. Meanwhile the buyer has no reason to expect an antidepressant herb in a memory capsule, and will not think to mention it when a doctor asks what they are taking.
What to actually do
Read the full ingredient list before you buy
Not the headline. St John's wort appears in mood, sleep, menopause and cognitive formulas, often without prominence.
Take the list to a pharmacist
With your actual medications. This is the single highest-value two minutes in this whole article, and it costs nothing.
Tell every prescriber you take it
Supplements routinely go unmentioned in medication reviews. This one needs to be on the list.
Do not stop suddenly if you are on a serotonergic drug
Stopping St John's wort abruptly changes the clearance of other medicines too. Changes should be managed, not improvised.
The fair conclusion
St John's wort is not a dangerous plant. It is an effective one with a well-mapped, well-documented interaction profile, and it is used safely by a great many people who are not taking anything it interferes with. The failure here is not the ingredient — it is selling it inside a product whose buyers have no reason to look for it, on a page that never mentions why they should.
See all seven doses side by side
Every published amount against every trial dose, the interaction warning in full, and today's official-store pricing — on one page.
Order NowFrequently asked questions
Can I take this with the contraceptive pill?
Not without medical advice. St John's wort is documented to reduce contraceptive hormone levels, with breakthrough bleeding and unintended pregnancies reported. Your prescriber may advise additional contraception or a different product entirely.
Can I take it with an SSRI?
This combination risks serotonin syndrome and should only happen under medical supervision. Do not add it to an antidepressant on your own, and do not stop your antidepressant in order to take it.
Is 250 mg too small to matter?
Possibly, but you cannot tell from the label. Induction is driven by hyperforin content, which labels rarely state — the '0.3% extract' figure refers to hypericin, a different compound. Ask a pharmacist rather than assuming.